Identifying opportunities for optimising the management of high-risk COPD patients in Australia: an observational study
Dickens, A. P., Jenkins, C., Evans, A., Hancock, K., Sharma, A., Cochrane,, B., Leong, P., Ko, B., Heraud, F., Le Cheng, P., Roussos, A., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Ghisla, C., Le, T., Le Lievre, C. E., Murray, R., Ranasinghe, K., Stewart, D., van Melle, M., Vella, R., Wiseman, R., Price, D.
The association between short-acting β2-agonist over-prescription, and patient-reported acquisition and use on asthma control and exacerbations: data from Australia
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Beekman, M. J., Bosnic-Anticevich, S., Botini, F., Carter, V., Catanzariti, A., Doan, J., Fletton, K., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Stewart, D., Willet, B., OPCA Improving Asthma outcomes in Australia Research Group, Bateman, E.
The future of allergic rhinitis management: a partnership between health care professionals and patients
Cvetkovski, B., Muscat, D. M., Bousquet, J., Cabrera, M., House, R., Katsoulotos, G., Lourenço, O. M., Papadopoulos, N., Price, D., Rimmer, J., Ryan, D., Smith, P., Yan, K. Y., Bosnic-Anticevich, S.
World Allergy Organization Journal, vol. 17, no. 3, 100873
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
Chen, W., Tran, T. N., Sadatsafavi, M., Murray, R. B., Boon Wong, N. C., Ali, N., Ariti, C., Bulathsinhala, L., Garcia Gil, E., FitzGerald, J. M., Alacqua, M., Al-Ahmad, M., Altraja, A., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A., Bourdin, A., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G. C., Cosio, B. G., Costello, R. W., Fonseca, J. A., Gibson, P. G., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Koh, M. S., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L., Lyu, J., Mahboub, B., Maspero, J., Menzies-Gow, A. N., Newell, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez-de-Llano, L., Perng (Steve), D., Peters, M. J., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Ra, S. W., Wang, E., Wechsler, M. E., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 12, no. 2, pp. 536-539
Association between T2-related co-morbidities and effectiveness of biologics in severe asthma
Wechsler, M. E., Scelo, G., Larenas-Linnemann, D. E., Torres-Duque, C. A., Maspero, J. F., Tran, T. N., Murray, R. B., Martin, N., Menzies-Gow, A., Hew, M., Peters, M. J., Gibson, P. G., Christoff, G. C., Popov, T. A., Côté, A., Bergeron, C., Dorscheid, D., FitzGerald, J. M., Chapman, K. R., Boulet, L. P., Bhutani, M., Jiménez-Maldonado, L., Duran-Silva, M., Rodriguez, B., Celis-Preciado, C. A., Cano-Rosales, D. J., Solarte, I., Fernandez-Sanchez, M. J., Parada-Tovar, P., von Bülow, A., Bjerrum, A. S., Suppli Ulrik, C., Assing, K. D., Rasmussen, L. M., Hansen, S., Altraja, A., Bourdin, A., Taillé, C., Charriot, J., Roche, N., Papaioannou, A. I., Kostikas, K., Papadopoulos, N. G., Salvi, S., Long, D., Mitchell, P., Costello, R. W., Sirena, C., Cardini, C., Heffler, E., Puggioni, F., Canonica, G. W., Guida, G., Iwanaga, T., Al-Ahmad, M., García, U., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Koh, M. S., Rhee, C. K., Cosio, B. G., Perez de Llano, L., Perng, D. W., Wan-Chun Huang, E., Wang, H., Tsai, M., Mahboub, B., Salameh, L. I. J., Jackson, D. J., Busby, J., Heaney, L. G., Pfeffer, P. E., Goddard, A. G., Wang, E., Hoyte, F. C., Chapman, N. M., Katial, R., Carter, V., Bulathsinhala, L., Eleangovan, N., Ariti, C., Lyu, J., Porsbjerg, C., Price, D., Sadatsafavi, M.
American Journal of Respiratory and Critical Care Medicine, vol. 209, no. 3, pp. 262-272
Development of theoretically informed audit and feedback: an exemplar from a complex implementation strategy to improve asthma self-management in UK primary care
McClatchey, K., Sheldon, A., Steed, L., Sheringham, J., Holmes, S., Preston, M., Appiagyei, F., Price, D., Taylor, S. J., Pinnock, H., IMP2ART Programme Group.
Journal of Evaluation in Clinical Practice, vol. 30, no. 1, pp. 86-100
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
Scadding, G. K., McDonald, M., Backer, V., Scadding, G., Bernal-Sprekelsen, M., Conti, D. M., De Corso, E., Diamant, Z., Gray, C., Hopkins, C., Jesenak, M., Johansen, P., Kappen, J., Mullol, J., Price, D., Quirce, S., Reitsma, S., Salmi, S., Senior, B., Thyssen, J. P., Wahn, U., Hellings, P. W.
Risk of pneumonia in patients with COPD initiating fixed dose inhaled corticosteroid (ICS) / long-acting bronchodilator (LABD) formulations containing extrafine beclometasone dipropionate versus patients initiating LABD without ICS
Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C. F., Nudo, E., Carter, V., Skinner, D., Vella, R., Soriano, J. B., Kots, M., Georges, G.
Pragmatic and Observational Research, vol. 15, pp. 1-16
